You are here:

Category: 8.3 Sex hormones and hormone antagonists in malignant disease

Name SMC ID No Manufacturer Status Sub. Type
 
abiraterone (Zytiga) 764/12 Janssen-Cilag Ltd Not Recommended Full submission
abiraterone (Zytiga) 764/12 Janssen-Cilag Ltd Restricted Resubmission
abiraterone (Zytiga) 873/13 Janssen-Cilag Ltd Accepted IRP
abiraterone (Zytiga) 873/13 Janssen-Cilag Ltd Not Recommended Full submission
Anastrozole (Arimidex®) 90/04 AstraZeneca UK Ltd Restricted Full submission
anastrozole 1mg tablet (Arimidex) 322/06 AstraZeneca UK Ltd Restricted Full submission
Anastrozole 1mg tablets (Arimidex®) 198/05 AstraZeneca UK Ltd Restricted Full submission
Decapeptyl SR 11.25 mg (Triptorelin acetate®) 109/04 Ipsen Ltd Accepted Abbreviated Submission
degarelix (Firmagon) 560/09 Ferring Pharmaceuticals Ltd Not Recommended Full submission
degarelix (Firmagon) 560/09 Ferring Pharmaceuticals Ltd Accepted Resubmission
enzalutamide (Xtandi) 1066/15 Astellas Pharma Ltd Accepted IRP
enzalutamide (Xtandi) 1066/15 Astellas Pharma Ltd Not Recommended Full submission
Exemestane 25mg tablets (Aromasin®) 210/05 Pfizer Ltd Superseded Full submission
fulvestrant (Faslodex) 114/04 AstraZeneca UK Ltd Accepted Resubmission
Fulvestrant (Faslodex®) 114/04 AstraZeneca UK Ltd Not Recommended Full submission
Gonapeptyl depot 3.75mg 269/06 Ferring Pharmaceuticals Ltd Not Recommended Non submission
Gonapeptyl depot 3.75mg 270/06 Ferring Pharmaceuticals Ltd Not Recommended Non submission
histrelin acetate (Vantas) 557/09 Orion Pharma (UK) Ltd Restricted Full submission
Lanreotide (Somatuline® LA) 231/06 Ipsen Ltd Not Recommended Non submission
letrozole (Femara) 251/06 Novartis Pharmaceuticals UK Ltd Restricted Full submission
Letrozole (Femara®) 152/05 Novartis Pharmaceuticals UK Ltd Restricted Full submission
pasireotide (as pamoate) (Signifor) 1048/15 Novartis Pharmaceuticals UK Ltd Accepted Full submission
radium 223 (Xofigo) 1077/15 Bayer plc/Bayer Schering Pharma Accepted Full submission
Triptorelin 11.25mg injection (Decapeptyl SR®) 207/05 Ipsen Ltd Accepted Abbreviated Submission

Back